Diagnostics & biomarkers

Lifelong exercise protects the heart. It can also make the heart harder to read

If BMI misses cardiovascular risk, why is policy still built around it?

Low testosterone in young men may be a metabolic warning sign, not a treatment target

Severe preeclampsia may leave a measurable signature in the fetal heart

One Blood Test for 50 Cancers Is Closer to the FDA. The Evidence Is Still Fighting Back.

Genomics Is Becoming an Acute Neurology Test

Preparedness Finally Has Capital

Precision Oncology Has a Scale Problem

Alzheimer’s Blood Tests Are Changing Decisions, Not Just Diagnoses
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
